Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
Rev. Soc. Bras. Med. Trop; 53 (), 2020
Publication year: 2020
Abstract INTRODUCTION:
Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance.METHODS:
Data were obtained from ICUs between 2010 and 2013.RESULTS:
P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidrug resistant. We observed increasing resistance to carbapenems and polymyxin B and growing consumption of aminoglycosides, meropenem, ceftazidime, and polymyxin B. The regression impact between resistance and consumption was significant with respect to amikacin, imipenem, meropenem, and polymyxin B.CONCLUSIONS:
Monitoring antimicrobial consumption and resistant microorganisms should be reinforced to combat antimicrobial- and multi-drug resistance.
Antibacterianos/farmacología, Infección Hospitalaria/microbiología, Farmacorresistencia Bacteriana Múltiple, Unidades de Cuidados Intensivos, Pruebas de Sensibilidad Microbiana, Prevalencia, Infecciones por Pseudomonas/microbiología, Pseudomonas aeruginosa/efectos de los fármacos, Pseudomonas aeruginosa/aislamiento & purificación